Quantcast
Last updated on April 23, 2014 at 10:28 EDT

Latest RNA interference Stories

2014-04-21 23:02:46

Transparency Market Research Report Added "Research Report on Micro-RNA Market Analysis, Trends And Forecast, 2013 - 2019" to its database. Browse Full Report: http://www.transparencymarketresearch.com/micro-rna-market.html. Albany, New York, USA (PRWEB) April 21, 2014 Transparency Market Research Reports included a detailed market survey and analysis trends on “Micro-RNA Market”. This report also includes more info about basic overview of the industry including definitions,...

2014-03-31 20:22:14

DUBLIN, April 1, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/5wxkx8/global_rna ) has announced the addition of the "Global RNA Interference (RNAi) Therapy Market Outlook 2018" [http://www.researchandmarkets.com/research/5wxkx8/global_rna ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The popularity of RNAi technology has been increasing in recent times as is has become a major...

2014-03-14 08:26:59

WESTBOROUGH, Mass., March 14, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced upcoming presentations at the 6th Ocular Diseases and Drug Development Conference, the 72(nd) Annual Meeting of the American Academy of Dermatology ("AAD") and the Keystone Symposia Meeting, Fibrosis:...

2014-03-13 23:03:47

ReportsnReports.com adds “Global RNA Interference (RNAi) Therapy Market Outlook 2018” reports to its vast collection of research databases. Dallas, Texas (PRWEB) March 13, 2014 The popularity of RNAi technology has been increasing in recent times as it has become a major component of basic research and in drug discovery. Over the years, this technology has become an integral part of the process of determining the functions of genes, in analyzing pathways, and in the validation of the...

2014-03-05 08:28:39

WESTBOROUGH, Mass., March 5, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it has been granted a patent by the U.S. Patent and Trademark Office on its unique self-delivering RNAi compounds (sd-rxRNA®), for the treatment of fibrosis. The patent covers the use of sd-rxRNAs...

2014-03-04 08:31:33

WESTBOROUGH, Mass., March 4, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company's President & CEO, Dr. Geert Cauwenbergh, will present at the 26(th) Annual ROTH Conference on Tuesday, March 11, 2014 at 4:30pm PST. Dr. Cauwenbergh will discuss the development of...

2014-02-24 12:27:26

SAN DIEGO, Feb. 24, 2014 /PRNewswire/ -- Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing rare diseases, today announced it will present at BIOCOM's Global Life Science Partnering Conference being held on February 26 and 27, 2014 at the Lodge in Torrey Pines, La Jolla, California. In addition to providing an update on its flagship program targeting transthyretin (TTR)-mediated amyloidosis, Arcturus will present data for its proprietary LUNAR(TM) delivery...

2014-02-24 08:27:38

WESTBOROUGH, Mass., Feb. 24, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company's President & CEO, Dr. Geert Cauwenbergh, will present at the 24(th) Annual Wall Street Analyst Forum on Monday, March 3, 2014 at 12:50pm EST. Dr. Cauwenbergh will discuss the...

2014-02-11 08:31:39

WESTBOROUGH, Mass., Feb. 11, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, announced today that the Company received approval by The NASDAQ Stock Market LLC's ("NASDAQ") Listing Qualification Department to list its common stock on the NASDAQ Capital Market. The Company's common stock will...

2014-02-07 12:48:23

Protein controls editing, expanding the information content of DNA An international team of researchers, led by scientists from the University of California, San Diego School of Medicine and Indiana University, have identified a protein that broadly regulates how genetic information transcribed from DNA to messenger RNA (mRNA) is processed and ultimately translated into the myriad of proteins necessary for life. The findings, published today in the journal Cell Reports, help explain how...


Latest RNA interference Reference Libraries

Blue Rose
2013-10-02 08:33:40

A Blue Rose is a flower of the genus Rosa belonging to the family Rosaceae that presents blue to violet pigmentation instead of the more common white, red, or yellow coloration. Blue roses are frequently portrayed in literature and art as a symbol of love and prosperity to those who seek it, but don’t exist in nature as a result of genetic limitations. In 2004, researchers utilized genetic modification to produce roses that contain the blue pigment delphinidin. After 13 years of...

Caenorhabditis elegans
2014-01-12 00:00:00

Caenorhabditis elegans is a species of parasitic roundworm in the Nematoda phylum. It can be found in temperate regions, in many different areas of the world. It prefers to reside in nutrient rich soils. Its scientific name is derived from the Greek terms Caeno, meaning recent, rhabditis, meaning rod-like, and the Latin term elegans, which means elegant. It was first named by Maupas in 1900, but was not classified in the Caenorhabditis subgenus until 1952 by Osche. Caenorhabditis elegans...

More Articles (2 articles) »